Cargando…

Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art

Respiratory tract infections (RTIs) are a leading cause of morbidity and also represent a cause of death in some parts of the world. The treatment of RTIs implies a continuous search for stronger therapies and represents an economical burden for health services and society. In this context the preve...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Benedetto, Fernando, Sevieri, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679713/ https://www.ncbi.nlm.nih.gov/pubmed/23692890 http://dx.doi.org/10.1186/2049-6958-8-33

Ejemplares similares

Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
por: Ballarini, Stefania, et al.
Publicado: (2022)

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
por: Antunes, Krist Helen, et al.
Publicado: (2022)

Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85
por: Esposito, Susanna, et al.
Publicado: (2022)

Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021)

The OM-85 bacterial lysate: a new tool against SARS-CoV-2?
por: Pivniouk, Vadim, et al.
Publicado: (2023)

Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
por: Koatz, Ana M., et al.
Publicado: (2016)

Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study
por: Bodemer, Christine, et al.
Publicado: (2017)

Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance
por: TROIANO, GIANMARCO, et al.
Publicado: (2021)

OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
por: Fang, Lei, et al.
Publicado: (2021)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response
por: Baladi, S., et al.
Publicado: (1994)

Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers
por: Berber, Arturo, et al.
Publicado: (2019)

Impact of OM-85 Given during Two Consecutive Years to Children with a History of Recurrent Respiratory Tract Infections: A Retrospective Study
por: Esposito, Susanna, et al.
Publicado: (2019)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

OM-85 is an immunomodulator of interferon-β production and inflammasome activity
por: Dang, A. T., et al.
Publicado: (2017)

158 Efficacy of Immnunotherapy with an Oral Bacterial Lysate and Vitamin C in the Primary Prevention of Acute Respiratory Tract Infections in Children
por: Socci, Miguel, et al.
Publicado: (2012)

Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice
por: Rossi, Giovanni A., et al.
Publicado: (2018)

Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections
por: Braido, F, et al.
Publicado: (2007)

A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections
por: Esposito, Susanna, et al.
Publicado: (2019)

Bacterial Lysates as Immunotherapies for Respiratory Infections: Methods of Preparation
por: Suárez, Norma, et al.
Publicado: (2020)

Effectiveness of Polyvalent Bacterial Lysate and Autovaccines Against Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study
por: Zagólski, Olaf, et al.
Publicado: (2015)

Prospective Study in Children with Complicated Urinary Tract Infection Treated with Autologous Bacterial Lysates
por: Hernández-Chiñas, Ulises, et al.
Publicado: (2021)

Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study
por: Gao, Jinming, et al.
Publicado: (2021)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial
por: Gao, Jinming, et al.
Publicado: (2014)

OM-85 BV for primary prevention of recurrent airway infections: a pilot randomized, double-blind, placebo-controlled study
por: de Souza, Fátima Cleonice, et al.
Publicado: (2020)

Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM‐85
por: Lauzon‐Joset, Jean‐Francois, et al.
Publicado: (2021)

Effect and Analysis of Bacterial Lysates for the Treatment of Recurrent Urinary Tract Infections in Adults
por: Ahumada-Cota, Ricardo E., et al.
Publicado: (2020)

Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art
por: Das, Shubhagata, et al.
Publicado: (2018)

IRF7-Associated Immunophenotypes Have Dichotomous Responses to Virus/Allergen Coexposure and OM-85-Induced Reprogramming
por: de Jong, Emma, et al.
Publicado: (2021)

Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway
por: Parola, Carmen, et al.
Publicado: (2013)

Effect of aerosolized bacterial lysate on development of naturally occurring respiratory disease in beef calves
por: Bassel, Laura L., et al.
Publicado: (2021)

Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections
por: Huang, Zheng, et al.
Publicado: (2021)

Health Tract, No. 85: The Sabbath Rest
Publicado: (1862)

Health Tract, No. 85: The Sabbath Rest
Publicado: (1865)

Distinct Antiviral Properties of Two Different Bacterial Lysates
por: Roth, Michael, et al.
Publicado: (2021)

Promising Immunomodulatory Effects of Bacterial Lysates in Allergic Diseases
por: Kaczynska, Agnieszka, et al.
Publicado: (2022)

Identifying Organic Matter (OM) Types and Characterizing OM Pores in the Wufeng–Longmaxi Shales
por: Xie, Guoliang, et al.
Publicado: (2022)

A Case-Control Study on the Changes in Natural Killer Cell Activity following Administration of Polyvalent Mechanical Bacterial Lysate in Korean Adults with Recurrent Respiratory Tract Infection
por: Lee, Yun Kyong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hp25299jb5ku0fu0g8sak3f4kh